The Effect of Age in Patients with Triple Vessel CAD Undergoing PCI vs. Surgery

Original Title: Effects of Age and Sex on Clinical Outcomes after Percutaneous Coronary Intervention Relative to Coronary Artery Bypass Grafting in Patients with Triple Vessel Coronary Artery Disease. Reference: KyoheiYamaji et al. Circulation. 2016 Mar 23. [Epub ahead of print].

 

Sex and age are factors that are often considered in the daily practice to decide between PCI or surgery.

The multicenter CREDO-Kyoto trial included 25816 patients; 5651 (men n=3998 and women n=1653) had triple vessel CAD and were considered good candidates for revascularization both with PCI and CABG (PCI n=3,165 and CABG n=2,486).

Patients were divided in three groups according to age tertile: ≤65 years (n=1,972), 66-73 years (n=1,820), and ≥74 years (n=1,859).

There was an excess mortality risk in ≥74 year old patients undergoing PCI compared to those undergoing CABG (HR 1.40, CI 95% 1.10 to 1.79; p=0.006), whereas this risk was neutral for ≤65 year old patients (HR 1.05, CI 95% 0.73 to 1.53; p=0.78) and also neutral for the group between 66 and 73 years of age (HR 1.03, CI 95% 0.78 to 1.36; p=0.85).

The excess mortality risk in the PCI group was significant in men (HR 1.24, CI 95% 1.03 to 1.50; p=0.02) and tended to be significant in women (HR 1.34 IC 95% 0.98 a 1.84; p=0.07).

Conclusion
There was a significant association between age and mortality risk in ≥74 year old patients with triple vessel CAD undergoing PCI compared to those undergoing CABG. The risk was neutral in younger patients.

More articles by this author

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | FLAVOUR II: Angiography-Derived FFR-Guided vs. IVUS-Guided PCI

Physiological assessment is effective when it comes to decision-making for percutaneous coronary intervention (PCI). However, despite the available evidence, its use remains limited. AngioFFR...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...